Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227
4 意见
administrator
07/30/23
For more information, visit https://ascopubs.org/doi/full/10.1200/JCO.22.01503
显示更多
脸书评论
没有找到评论